These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 35315393)
1. SARS-CoV-2 Variants of Concern Increased Transmission and Decrease Vaccine Efficacy in the COVID-19 Pandemic in Palembang Indonesia. Ghiffari A; Anwar C; Hasyim H; Iskandar I; Kamaluddin MT Acta Biomed; 2022 Mar; 93(1):e2022018. PubMed ID: 35315393 [TBL] [Abstract][Full Text] [Related]
2. Genome Profiling of SARS-CoV-2 in Indonesia, ASEAN and the Neighbouring East Asian Countries: Features, Challenges and Achievements. Cahyani I; Putro EW; Ridwanuloh AM; Wibowo S; Hariyatun H; Syahputra G; Akbariani G; Utomo AR; Ilyas M; Loose M; Kusharyoto W; Susanti S Viruses; 2022 Apr; 14(4):. PubMed ID: 35458508 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 transmissibility compared between variants of concern and vaccination status. Wang L; Didelot X; Bi Y; Gao GF Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35062017 [TBL] [Abstract][Full Text] [Related]
5. Viruses, variants and vaccines. Cowan DA; Burton SG; Rybicki EP; Wiliamson AL; Dorrington RA; Pepper MS S Afr Med J; 2021 Mar; 111(5):409-411. PubMed ID: 34852879 [TBL] [Abstract][Full Text] [Related]
6. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021. Bui NN; Lin YT; Huang SH; Lin CW Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective. Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235 [TBL] [Abstract][Full Text] [Related]
9. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
10. Post-vaccination cases of COVID-19 among healthcare workers at Siloam Teaching Hospital, Indonesia. Cucunawangsih C; Wijaya RS; Lugito NPH; Suriapranata I Int J Infect Dis; 2021 Jun; 107():268-270. PubMed ID: 33992761 [TBL] [Abstract][Full Text] [Related]
11. The COVID-19 pandemic: viral variants and vaccine efficacy. Ciotti M; Ciccozzi M; Pieri M; Bernardini S Crit Rev Clin Lab Sci; 2022 Jan; 59(1):66-75. PubMed ID: 34598660 [TBL] [Abstract][Full Text] [Related]
12. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern. Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323 [TBL] [Abstract][Full Text] [Related]
13. A Single Vaccine Protects against SARS-CoV-2 and Influenza Virus in Mice. Cao K; Wang X; Peng H; Ding L; Wang X; Hu Y; Dong L; Yang T; Hong X; Xing M; Li D; Zhu C; He X; Zhao C; Zhao P; Zhou D; Zhang X; Xu J J Virol; 2022 Feb; 96(4):e0157821. PubMed ID: 34908443 [TBL] [Abstract][Full Text] [Related]
14. Large-scale synchronized replacement of Alpha (B.1.1.7) variant by the Delta (B.1.617.2) variant of SARS-COV-2 in the COVID-19 pandemic. Liu Y; Feng A; Zhao S; Wang W; He D Math Biosci Eng; 2022 Feb; 19(4):3591-3596. PubMed ID: 35341265 [TBL] [Abstract][Full Text] [Related]
15. CoV-Seq, a New Tool for SARS-CoV-2 Genome Analysis and Visualization: Development and Usability Study. Liu B; Liu K; Zhang H; Zhang L; Bian Y; Huang L J Med Internet Res; 2020 Oct; 22(10):e22299. PubMed ID: 32931441 [TBL] [Abstract][Full Text] [Related]
16. Rapid evolution of the COVID-19 pandemic calls for a unified public health response. He N Biosci Trends; 2021 Sep; 15(4):196-200. PubMed ID: 34193749 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 genetic diversity and variants of concern in Saudi Arabia. Obeid DA; Alsanea MS; Alnemari RT; Al-Qahtani AA; Althawadi SI; Mutabagani MS; Almaghrabi RS; Alhadheq FM; Alahideb BM; Alhamlan FS J Infect Dev Ctries; 2021 Dec; 15(12):1782-1791. PubMed ID: 35044933 [TBL] [Abstract][Full Text] [Related]
18. Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using Boon SS; Xia C; Wang MH; Yip KL; Luk HY; Li S; Ng RWY; Lai CKC; Chan PKS; Chen Z mBio; 2021 Oct; 12(5):e0268721. PubMed ID: 34700382 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study. Li XN; Huang Y; Wang W; Jing QL; Zhang CH; Qin PZ; Guan WJ; Gan L; Li YL; Liu WH; Dong H; Miao YT; Fan SJ; Zhang ZB; Zhang DM; Zhong NS Emerg Microbes Infect; 2021 Dec; 10(1):1751-1759. PubMed ID: 34396940 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Transmission to Masked and Unmasked Close Contacts of University Students with COVID-19 - St. Louis, Missouri, January-May 2021. Rebmann T; Loux TM; Arnold LD; Charney R; Horton D; Gomel A MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(36):1245-1248. PubMed ID: 34499631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]